v3.25.2
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net loss $ (6,674,000) $ (8,333,000)
Adjustments to reconcile net loss to net cash provided by (used in) used in operating activities:    
Depreciation and amortization 1,002,000 1,045,000
Stock-based compensation 979,000 1,571,000
Amortization of debt issuance costs 164,000 230,000
Non-cash lease expense 667,000 606,000
Inventory write downs 534,000 490,000
Changes in operating assets and liabilities:    
Accounts receivable (1,723,000) (973,000)
Inventories (788,000) (1,309,000)
Other assets (1,085,000) (163,000)
Accounts payable 5,022,000 1,523,000
Accrued expenses 3,132,000 745,000
Accrued interest 120,000 124,000
Office leases payable (734,000) (644,000)
Deferred revenue (26,000) 354,000
Customer deposits 20,000 (64,000)
Net cash provided by (used in) operating activities 610,000 (4,798,000)
Cash flows from investing activities:    
Purchases of equipment (653,000) (853,000)
Net cash used in investing activities (653,000) (853,000)
Cash flows from financing activities:    
Proceeds from employee stock purchase plan exercises 97,000 141,000
Proceeds from subordinated debt borrowing 1,000,000
Proceeds from revolving line of credit 64,463,000 67,209,000
Payment of revolving line of credit (64,670,000) (63,287,000)
Payment of finance leases (156,000) (148,000)
Net cash provided by financing activities 734,000 3,915,000
Net change in cash 691,000 (1,736,000)
Cash, beginning of period 643,000 2,379,000
Cash, end of period 1,334,000 643,000
Supplemental Disclosures of Non-Cash Investing and Financing Activities:    
Common stock issued for vested RSUs 161,000 538,000
Warrants issued in connection with borrowing agreements, recorded as debt issuance cost 92,000
Supplemental cash flow information:    
Interest paid $ 1,235,000 $ 1,409,000

Source

PDF HTML 10-K Filing
ZIP XLS HTML XBRL